HRT Financial’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$158K Sell
54,733
-135,362
-71% -$289K ﹤0.01% 3251
2025
Q4
$306K Buy
+190,095
New +$299K ﹤0.01% 2363
2025
Q3
Sell
-102,714
Closed -$124K 3348
2025
Q2
$124K Buy
102,714
+71,544
+230% +$104K ﹤0.01% 2167
2025
Q1
$39K Buy
+31,170
New +$81.4K ﹤0.01% 2256
2024
Q3
Sell
-75,042
Closed -$318K 2850
2024
Q2
$318K Buy
+75,042
New +$731K ﹤0.01% 1486
2023
Q4
Sell
-90,540
Closed -$421K 2781
2023
Q3
$421K Sell
90,540
-63,534
-41% -$316K ﹤0.01% 1489
2023
Q2
$824K Sell
154,074
-77,853
-34% -$480K 0.01% 1066
2023
Q1
$1.66M Buy
231,927
+92,914
+67% +$560K 0.02% 689
2022
Q4
$932K Sell
139,013
-30,373
-18% -$167K 0.01% 1018
2022
Q3
$586K Sell
169,386
-164,636
-49% -$630K 0.01% 1328
2022
Q2
$985K Buy
+334,022
New +$1.76M 0.01% 947
2022
Q1
Sell
-73,296
Closed -$1.18M 3550
2021
Q4
$1.18M Sell
73,296
-20,012
-21% -$377K 0.01% 985
2021
Q3
$1.95M Buy
+93,308
New +$2.25M 0.01% 755
2021
Q2
Sell
-7,724
Closed -$246K 3258
2021
Q1
$246K Buy
+7,724
New +$188K ﹤0.01% 2212

Other funds holding MGNX

HRT Financial's MGNX Position: Q1 2026 in Review

HRT Financial reduced its MacroGenics (MGNX) stake by 71% in Q1 2026, selling an estimated $289K and leaving 54,733 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #3251.

HRT Financial first reported a position in MGNX in Q1 2021 and has held it in 14 quarters since. The position peaked at $1.95M in Q3 2021. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • HRT Financial held 54,733 shares of MacroGenics worth $158K as of Q1 2026.
  • HRT Financial sold 135,362 MacroGenics shares in Q1 2026, an estimated $289K.
  • MacroGenics made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3251 holding.
  • HRT Financial first reported a position in MacroGenics in Q1 2021 and has held it in 14 quarters since.
  • HRT Financial's MacroGenics position peaked at $1.95M in Q3 2021.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.